These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 34169384)
1. miR-181b-5p Promotes the Progression of Cholangiocarcinoma by Targeting PARK2 via PTEN/PI3K/AKT Signaling Pathway. Jiang ZL; Zhang FX; Zhan HL; Yang HJ; Zhang SY; Liu ZH; Jiang Y; Lv LZ; Ke RS Biochem Genet; 2022 Feb; 60(1):223-240. PubMed ID: 34169384 [TBL] [Abstract][Full Text] [Related]
2. Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling. Wang Y; Liang Y; Yang G; Lan Y; Han J; Wang J; Yin D; Song R; Zheng T; Zhang S; Pan S; Liu X; Zhu M; Liu Y; Cui Y; Meng F; Zhang B; Liang S; Guo H; Liu Y; Hassan MK; Liu L J Exp Clin Cancer Res; 2018 Dec; 37(1):300. PubMed ID: 30514341 [TBL] [Abstract][Full Text] [Related]
3. Targeting the PI3K/AKT/mTOR pathway offer a promising therapeutic strategy for cholangiocarcinoma patients with high doublecortin-like kinase 1 expression. Liang Z; Ge Y; Li J; Bai Y; Xiao Z; Yan R; An G; Zhang D J Cancer Res Clin Oncol; 2024 Jul; 150(7):342. PubMed ID: 38980538 [TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of celastrol by inhibition of proliferation, invasion, and migration in cholangiocarcinoma via PTEN/PI3K/Akt pathway. Zhu B; Wei Y Cancer Med; 2020 Jan; 9(2):783-796. PubMed ID: 31957323 [TBL] [Abstract][Full Text] [Related]
5. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling. Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424 [TBL] [Abstract][Full Text] [Related]
6. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
7. LINC00673 exerts oncogenic function in cervical cancer by negatively regulating miR-126-5p expression and activates PTEN/PI3K/AKT signaling pathway. Shi WJ; Liu H; Ge YF; Wu D; Tan YJ; Shen YC; Wang H; Xu H Cytokine; 2020 Dec; 136():155286. PubMed ID: 32950808 [TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1 promotes cell proliferation, migration, and invasion via the miR-186-5p/PTP4A1 axis in cholangiocarcinoma. Li O; Jiang B; Yi WM; Zhang Y; Yang PZ; Guo C; Sun ZP; Peng C Kaohsiung J Med Sci; 2021 May; 37(5):379-391. PubMed ID: 33502823 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
10. Osteocyte-derived exosomes induced by mechanical strain promote human periodontal ligament stem cell proliferation and osteogenic differentiation via the miR-181b-5p/PTEN/AKT signaling pathway. Lv PY; Gao PF; Tian GJ; Yang YY; Mo FF; Wang ZH; Sun L; Kuang MJ; Wang YL Stem Cell Res Ther; 2020 Jul; 11(1):295. PubMed ID: 32680565 [TBL] [Abstract][Full Text] [Related]
11. MiR-22-3p Inhibits 5-Fluorouracil Resistance in Cholangiocarcinoma Cells Through PTEN/PI3K/AKT Axis. Zhang N; Zang L Assay Drug Dev Technol; 2024 Jul; 22(5):217-228. PubMed ID: 38967602 [No Abstract] [Full Text] [Related]
12. miR-382-5p promotes cell invasion in hepatocellular carcinoma by targeting PTEN to activate PI3K/Akt signaling pathway. Lv B; Liu X; Zhu X; Huang M World J Surg Oncol; 2022 Jun; 20(1):175. PubMed ID: 35655254 [TBL] [Abstract][Full Text] [Related]
13. Tip60 Suppresses Cholangiocarcinoma Proliferation and Metastasis via PI3k-AKT. Zhang Y; Ji G; Han S; Shao Z; Lu Z; Huo L; Zhang J; Yang R; Feng Q; Shen H; Wang H; Li X Cell Physiol Biochem; 2018; 50(2):612-628. PubMed ID: 30308494 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
15. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Liao G; Liu X; Wu D; Duan F; Xie X; Wen S; Li Y; Li S Aging (Albany NY); 2019 Jun; 11(11):3639-3649. PubMed ID: 31180332 [TBL] [Abstract][Full Text] [Related]
16. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447 [TBL] [Abstract][Full Text] [Related]
17. miR-378 serves as a prognostic biomarker in cholangiocarcinoma and promotes tumor proliferation, migration, and invasion. Zhou Z; Ma J Cancer Biomark; 2019; 24(2):173-181. PubMed ID: 30594918 [TBL] [Abstract][Full Text] [Related]
18. ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation. Wang Z; Wu S; Wang G; Yang Z; Zhang Y; Zhu C; Qin X Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676763 [No Abstract] [Full Text] [Related]
19. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
20. A PLCB1-PI3K-AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression. Liang S; Guo H; Ma K; Li X; Wu D; Wang Y; Wang W; Zhang S; Cui Y; Liu Y; Sun L; Zhang B; Xin M; Zhang N; Zhou H; Liu Y; Wang J; Liu L Cancer Res; 2021 Dec; 81(23):5889-5903. PubMed ID: 34580062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]